188.42 USD
-0.79 (-0.42%)
AT CLOSE (11:59 AM EDT)
AstraZeneca PLC (AZN)
NYSE: AZN • USD
190.09
+1.67 (+0.89%)
POST MARKET (AS OF 08:15 PM EDT)
Market: CLOSED
Open?$190.88
High?$192.97
Low?$187.95
Prev. Close?$188.42
Volume?2.8M
Avg. Volume?1.9M
VWAP?$190.41
Rel. Volume?1.43x
Bid / Ask
Bid?$189.00 × 100
Ask?$191.17 × 1.8K
Spread?$2.17
Midpoint?$190.08
Valuation & Ratios
Market Cap?292.2B
Shares Out?N/A
P/E Ratio?201.38
P/B Ratio?19.67
EPS?$0.94
Dividend?0.81%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.87Weak
Quick Ratio?0.72Weak
Cash Ratio?0.33Low
Debt/Equity?1.77High
ValuationRICHLY VALUED
Score33/100
P/E?201.4PRICEY▾
P/B?19.67HIGH▾
P/S?16.13HIGH▾
P/FCF?322.2PRICEY▾
EV/EBITDA?72.9HIGH▾
EV/Sales?17.30HIGH▾
Returns & Efficiency
ROE?9.8%FAIR▾
ROA?2.3%WEAK▾
Cash Flow & Enterprise
FCF?$907.0M
Enterprise Value?$313.5B
Related Companies
Loading...
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.